PreveCeutical Medical Inc. (FRA:18H0)
Germany · Delayed Price · Currency is EUR 0.0080
-0.0030 (-27.27%)
Last updated: Dec 1, 2025, 8:19 AM CET
PreveCeutical Medical Statistics
Total Valuation
FRA:18H0 has a market cap or net worth of EUR 9.20 million. The enterprise value is 12.03 million.
| Market Cap | 9.20M |
| Enterprise Value | 12.03M |
Important Dates
The next estimated earnings date is Friday, December 5, 2025.
| Earnings Date | Dec 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 598.19M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.63% |
| Shares Change (QoQ) | +4.79% |
| Owned by Insiders (%) | 24.74% |
| Owned by Institutions (%) | n/a |
| Float | 450.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -2.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.42 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -22.76 |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.38 |
| Interest Coverage | -6.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -513.10% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 31.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -30.43% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 40.07 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.38M |
| Pretax Income | -1.62M |
| Net Income | -1.62M |
| EBITDA | -1.37M |
| EBIT | -1.38M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 2,660 in cash and 2.84 million in debt, giving a net cash position of -2.84 million.
| Cash & Cash Equivalents | 2,660 |
| Total Debt | 2.84M |
| Net Cash | -2.84M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.47M |
| Book Value Per Share | -0.01 |
| Working Capital | -4.53M |
Cash Flow
In the last 12 months, operating cash flow was -526,134 and capital expenditures -2,379, giving a free cash flow of -528,513.
| Operating Cash Flow | -526,134 |
| Capital Expenditures | -2,379 |
| Free Cash Flow | -528,513 |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:18H0 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.63% |
| Shareholder Yield | -1.63% |
| Earnings Yield | -17.61% |
| FCF Yield | -5.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 23, 2018. It was a forward split with a ratio of 5.
| Last Split Date | May 23, 2018 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |